Today I'm sending this email from Boston, where we're hosting our premiere event series — House Call.
House Call, much like our online community, is a gathering like no other. It feels current. Alive. A little unpredictable in a good way. Every edition brings smart people, real problems, and fresh ideas worth stealing.
This issue won’t recreate that in full, obviously. But it will at least bring you the ideas, updates, and sharpest bits worth carrying forward next week.
In this week's Freshpaint 5, we have:
An invitation to our next House Call event
A few words about pharma marketing from Viant
A smorgasbord of fresh job openings
But first, a product update that removes all the guesswork.
Product Update: Now, You're the Know-It-All
Most CRO tools stop at data. Freshpaint shows what to fix.
If you’ve ever tried to figure out why patients aren’t converting, you know the routine: one tool for analytics, another for funnels, another for heatmaps, another for session replay, maybe surveys on top of that. It’s a lot of tabs and not always a lot of clarity.
That’s why this week we’re highlighting Freshpaint’s CRO capabilities. Freshpaint brings those pieces together in one platform built for healthcare workflows and PHI-sensitive journeys, then uses Freshpaint AI to connect the signals, spot patterns, and show you what’s actually worth fixing.
What that means for marketers:
See what’s happening in the funnel
Understand how patients are actually experiencing the journey
Get clearer signal on why they’re dropping off
Spend less time digging through dashboards and more time improving conversion
Already a customer? Log into Freshpaint and look for AI and CRO in the nav, or reach out to your AM.
If you're under pressure to do more with less, show ROI, and keep pace with privacy shifts, you're exactly who House Call Laguna Beach is for.
Over two days, you will spend time with healthcare marketing leaders getting practical on things like:
how teams are improving conversion rates without increasing spend
how leaders are proving what is working and using that to defend or unlock budget
how to build a privacy-first data foundation that supports performance, revenue growth, and compliance
how peers are solving attribution, campaign efficiency, and measurement challenges inside complex healthcare orgs
This is not another cookie-cutter conference. House Call is a carefully designed, invite-only gathering where real conversations lead to real solutions. Freshpaint covers travel, hotel, meals, and the full event experience for qualified attendees, so there is no registration fee.
House Call Laguna Beach
Surf & Sand Laguna Beach 📍1555 S Coast Hwy, Laguna Beach, CA
We’ll discuss how ortho organizations are navigating evolving privacy requirements, consent and compliance considerations, AI adoption, attribution challenges, and changing patient acquisition strategies across today’s healthcare marketing landscape.
The Ortho Leaders Circle
Virtual Roundtable
📅 Thursday, June 11 ⏰ 2:30PM ET / 11:30AM PT 🔗Sign up now
Spend a summer evening with Freshpaint exploring one of the oldest working farmsteads in Tarrant County. Walk the historic grounds, tour preserved buildings, meet heritage farm animals, and discover what life was really like for pioneer families on the Grapevine Prairie.
Whether you're bringing the kids or looking for a unique local experience, this family-friendly gathering is an opportunity to connect with fellow healthcare leaders, enjoy great BBQ, and experience the history of Nash Farm.
Summer Nights at Nash Farm & Terry Black's BBQ
Grapevine, TX
📅 Thursday, June 25 ⏰ 5:30PM - 8:30PM CT 🔗Sign up now
Viant on About Pharma Marketing
When 83% of marketers can't connect website visits to prescription fills — and 62% of privacy leaders have only partial visibility into their own pixels — attribution doesn't just get noisy; it collapses at the exact handoffs that matter most.
That's the argument Viant's Andrew Rosen makes in his foreword to our new benchmark report, and the data backs him up: pharma doesn't just have a compliance problem. It has an infrastructure problem.
We surveyed 100 marketing leaders and 100 privacy leaders across top pharma and biopharma to find out where DTC and DTP performance is breaking down — and what high-performing teams are doing differently.
Inside:
Where signal loss is highest across the DTC/DTP journey
How common workarounds quietly cap performance
Why aligning privacy guardrails with marketing objectives is the new infrastructure requirement for growth
If compliance has turned every campaign into a negotiation, this benchmark will show you where the real gaps are — and what it takes to close them. Get your copy today!
Fresh Jobs
Jobs from the industry for anyone searching for their next gig!
.jpg?upscale=true&width=1196&upscale=true&name=Center%20aligned%20(my%20preference).jpg)
